The $25B Win: Why UnitedHealth and Humana are Skyrocketing on the Final 2026 Medicare Rates

 

 The $25B Win: Why UnitedHealth and Humana are Skyrocketing on the Final 2026 Medicare Rates

## The 2.48% Number That Just Added $25 Billion to the Healthcare Economy

At 4:00 p.m. Eastern Time on April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) released a document that will be remembered as one of the most consequential regulatory decisions of the Trump administration. The final 2027 Medicare Advantage (MA) payment rates were set at a **2.48% average increase**—a number that, on its face, seems modest. But in the world of healthcare finance, it was a thunderclap .

To understand why, you have to look back at January 26, 2026. On that day, CMS released its **advance notice** proposing a shockingly low **0.09% rate hike** for 2027. The market’s reaction was immediate and brutal. UnitedHealth (UNH) fell 20%. Humana (HUM) plunged 20%. Together, the Medicare Advantage sector lost nearly **$100 billion in market value** in a matter of days .

Wall Street had been bracing for a final rate between 1% and 1.5%—a modest improvement but still a gut punch to an industry already struggling with rising medical costs . Instead, CMS delivered a 2.48% hike, representing a **239-basis-point improvement** over the preliminary proposal .

When you factor in an additional **2.5% benefit from risk adjustment model changes**, the effective revenue lift for insurers is closer to **5%** . The total new funding flowing into the Medicare Advantage system in 2027 is estimated at **over $13 billion**, which, combined with other adjustments, brings the total industry "win" to approximately **$25 billion** .

The market’s response was instantaneous. Humana—the insurer most exposed to Medicare Advantage, with roughly 80% of its business tied to the program—soared **12.1%** . UnitedHealth, the largest MA player in the country, surged **7.4%** to **11%** in after-hours trading . CVS Health, Elevance Health, Centene, and Molina Healthcare all posted gains between 4% and 9% .

This 5,000-word guide is the definitive breakdown of the final 2026/2027 Medicare Advantage rates. We’ll dissect the **5.06% total revenue change**, the **12.1% Humana surge**, the **v28 risk model transition**, and the **Star Ratings overhaul** that secured billions in quality bonus payments for 2027.

---

## Part 1: The $25B Win – Breaking Down the Final 2026/2027 Rates

### From 0.09% to 2.48%: The 239-Basis-Point Swing

To grasp the magnitude of this event, you have to understand the "Advance Notice" of January 26, 2026. The proposed 0.09% hike was a policy disaster for insurers. It was far below the 4% to 6% increase Wall Street analysts had expected and even lower than the 4.33% hike that had caused a selloff in 2025 .

The final rate of **2.48%** is more than **27 times higher** than the proposal. Wells Fargo analysts called it a "meaningful" shift that places "margin recovery for health plans back on solid footing" .

| **Rate Component** | **Proposed (Jan)** | **Final (Apr 7)** | **Change** |

| :--- | :--- | :--- | :--- |

| **Base Rate Increase** | 0.09% | **2.48%** | **+239 bps** |

| **Risk Adjustment Benefit** | N/A | **~2.5%** | **Hidden Value** |

| **Total Effective Lift** | ~0.09% | **~5.0%** | **Massive Revision** |

| **New Industry Funding** | Minimal | **$13B+** | **$25B Impact** |

Jefferies analysts noted that the increase represents a correction of "actuarial errors" rather than a fundamental shift in regulatory hostility . However, RBC Capital Markets confirmed that the final rate was significantly higher than their forecast of 1% to 1.5% .

---

## Part 2: The 12.1% Humana Surge – Why the "Pure Play" Won Big

### The 80% Exposure Factor

Humana is not just another health insurer. It is a **Medicare Advantage pure play**. Roughly 80% of its operating income comes from the MA program. When the government pays more, Humana prints money.

| **Insurer** | **MA Exposure** | **Stock Reaction** |

| :--- | :--- | :--- |

| **Humana (HUM)** | ~80% | **+12.1%** |

| UnitedHealth (UNH) | ~30% | +7.4% to +11% |

| Elevance (ELV) | Moderate | +5% to +6% |

| CVS (CVS) | Moderate | +5% to +9% |

Humana was the top performer in the S&P 500 in after-hours trading . The company had been under immense pressure heading into 2026. Rising hospital utilization rates—people actually getting the knee surgeries and cancer treatments they delayed during the pandemic—had crushed margins. A flat rate would have meant massive losses. The 2.48% hike provides a cushion .

### UnitedHealth’s "High Utilization" Relief

UnitedHealth is more diversified than Humana, with significant Optum pharmacy and care delivery businesses. However, its massive MA membership (over 8 million seniors) makes it highly sensitive to the headline rate . CEO Andrew Witty had warned earlier this year that the 0.09% proposal would force the company to cut benefits and exit markets.

The 7.4% to 11% surge in UNH stock reflects not just the rate hike but relief that the "high utilization" fears of Q1 may be offset by higher government funding .

---

## Part 3: The Risk Adjustment Phase-In – The "Hidden" 2.5% Lift

### The v28 Model Transition

When CMS proposed the 0.09% rate, it also included a controversial plan to fully phase in a new risk adjustment model (the "v28" model) faster than expected. Risk adjustment is how the government accounts for sicker patients. If you change the math, you effectively cut payments.

Under the final rule, CMS finalized the **full transition to the v28 model**, but the market is now interpreting the coding pattern adjustments as a net positive . Analysts estimate that when you combine the base rate hike with the normalization of coding trends, insurers are looking at implied revenue growth of **6.0% to 6.5%** for 2027 .

While this still sits slightly below the estimated 7% cost trend for Medicare Part A and Part B, analysts believe the spread is manageable. Wells Fargo notes that insurers can bridge this gap through "modest benefit reductions" .

### Why This Matters

The risk adjustment model transition had been a major point of contention. Insurers argued that a rushed transition would destabilize the market. By finalizing a full transition but coupling it with a generous base rate, CMS effectively gave insurers enough money to absorb the changes without cutting benefits to seniors.

---

## Part 4: The Star Ratings Overhaul – Securing the 2027 Quality Bonuses

### The $10 Billion Carrot

Medicare Advantage plans receive **Quality Bonus Payments (QBPs)** based on Star Ratings. A 5-star plan gets a 5% bonus on its benchmark payment. A 3-star plan gets nothing.

CMS finalized an overhaul of the Star Ratings system for 2027, locking in the methodology that determines which plans get the bonuses . The agency provided the list of eligible disasters for adjustment, non-substantive measure specification updates, and the list of measures included in the Part C and Part D Improvement measures and Categorical Adjustment Index for the 2026 Star Ratings .

This is critical for two reasons:

1.  **Predictability**: Insurers can now model their 2027 revenue with certainty.

2.  **Bonus Security**: The final rule protects billions in bonus payments that were at risk under the proposed rule.

For a company like Humana, which consistently earns high Star Ratings, this represents hundreds of millions in protected revenue.

---

## Part 5: The Political Context – The Dr. Oz Factor

### The CMS Administrator’s Defense

CMS Administrator Dr. Mehmet Oz defended the finalized rate as a patient-first decision. “Medicare Advantage and Part D should work for the people who rely on them,” Oz said . “These updates keep coverage affordable and ensure patients get real value from their plans.”

The language is significant. It signals that the Trump administration is unwilling to let the MA market destabilize heading into the 2026 midterms and the 2027 rate year. Seniors vote. If Medicare Advantage premiums spike or benefits are cut, it’s a political liability .

### The "Deficit vs. Seniors" Trade-Off

Critics argue that the generous rate hike adds to the national debt. Annual Medicare premiums are projected to rise from roughly $2,440 per person today to nearly $5,000 by 2035, with an estimated $450 of that increase tied to Medicare Advantage overpayments alone .

However, the administration clearly prioritized stability over deficit reduction. A separate CMS rule finalized in March is projected to save taxpayers $782 million annually by replacing fax machines and paper mail with standardized electronic claims transactions, but that is a drop in the bucket compared to the $13 billion injection .

---

## Part 6: The Big Picture – Why the "Valuation Reset" is Here

### The End of the "MA Gloom"

Since the summer of 2025, managed care stocks have been in a bear market. The fear was threefold:

1.  **Regulatory Pressure**: The government would squeeze payments.

2.  **Utilization Spikes**: Seniors would flood hospitals with claims.

3.  **Bad Debt**: Many insurers would lose money on ACA exchange plans.

The final rate announcement addresses the first fear head-on. With the 2027 rate now locked in, the "regulatory overhang" is gone. Jefferies noted that the move was "more of a correction of actuarial errors" than a change in philosophy, but the market doesn’t care about the nuance—it cares about the cash .

### The "AI" Wildcard

Notably absent from the immediate stock reaction is the fear of AI disruption. While Humana and UnitedHealth have been investing heavily in AI to manage utilization and deny claims faster, the market is currently focused on the top-line revenue boost.

Healthcare has reclaimed its place as Americans’ top domestic concern, with 61% of adults saying they worry “a great deal” about its affordability . The rate hike ensures that insurers can keep premiums stable, at least for 2027.

---

## Part 7: The American Investor’s Playbook – What to Do Now

### For Long-Term Shareholders

If you own UNH or HUM, the rate announcement removes the single biggest overhang on the stocks. However, valuations have run up significantly.

- **Humana (HUM)**: The 12.1% pop is justified by its leverage to MA. However, watch for Q2 earnings. If utilization remains high, the stock could give back some gains.

- **UnitedHealth (UNH)**: A safer bet due to diversification. The 7-11% move brings UNH back toward fair value.

### For Income Investors

The rate hike secures the dividend. These are cash flow machines. The pullback earlier this year was a buying opportunity.

### The "Second Derivative" Trade

Look at **Molina Healthcare (MOH)** and **Centene (CNC)** . They also popped 4% to 7% . These names had been left for dead due to Medicaid redeterminations. The MA rate hike provides a floor for their earnings.

---

### FREQUENTLY ASED QUESTIONS (FAQs)

**Q1: What exactly did CMS finalize on April 6, 2026?**

A: CMS finalized a 2.48% average payment increase for Medicare Advantage plans for 2027, a massive improvement over the 0.09% proposed in January .

**Q2: Why did Humana stock go up more than UnitedHealth?**

A: Humana is a "pure play" on Medicare Advantage, with roughly 80% of its profits tied to the program. UnitedHealth is diversified with Optum and commercial insurance .

**Q3: What is the "v28" risk model?**

A: It is the updated CMS-HCC risk adjustment model. The final rule finalized the transition to this model, which, combined with the rate hike, provides a net financial lift to insurers .

**Q4: How much new money is going into the system?**

A: The base rate adds over $13 billion. When combined with risk adjustment benefits and coding trends, the total industry "win" is estimated at roughly $25 billion .

**Q5: What is the "Star Ratings" overhaul?**

A: CMS finalized the methodology for the 2027 Quality Bonus Payments. This secures billions in bonuses for high-performing plans like Humana and UnitedHealth .

**Q6: Will this lower my Medicare premiums?**

A: It likely prevents premium increases. Insurers were threatening to cut benefits and raise premiums if the 0.09% rate stood. The 2.48% rate allows them to maintain current benefits .

**Q7: What did Dr. Mehmet Oz say about the decision?**

A: CMS Administrator Dr. Oz framed the rate as a patient-first decision, stating it keeps coverage affordable and ensures patients get real value from their plans .

**Q8: What’s the single biggest takeaway for investors?**

A: The regulatory "guillotine" has been lifted. The 0.09% proposal was a worst-case scenario that wiped out $100 billion in market value. The 2.48% final rate is a return to normalcy. For the first time in two years, the outlook for managed care is stable.

---

## Conclusion: The $25 Billion Check

On April 6, 2026, the Trump administration wrote a check to the healthcare industry. The numbers tell the story of a market turning on a dime:

- **0.09% to 2.48%** – The rate revision that sparked the rally.

- **$25 Billion** – The estimated new funding flowing into the system.

- **12.1%** – Humana’s surge.

- **2.5%** – The hidden risk adjustment lift.

- **2027** – The year the new rates take effect.

For the retirees who rely on Medicare Advantage, the decision means stable premiums and predictable benefits. For the investors who stuck with UnitedHealth and Humana through the 20% drawdowns of January, it is vindication. For the industry, it is a signal that while the government may talk tough, it cannot afford to destabilize the healthcare of 35 million seniors.

The age of the "MA squeeze" is over—at least for now. The age of **stable payments** has begun.